210 related articles for article (PubMed ID: 23669167)
21. An integrated approach to the diagnosis and prospective management of partial ornithine transcarbamylase deficiency.
Scaglia F; Zheng Q; O'Brien WE; Henry J; Rosenberger J; Reeds P; Lee B
Pediatrics; 2002 Jan; 109(1):150-2. PubMed ID: 11773558
[TBL] [Abstract][Full Text] [Related]
22. In vivo nitrogen metabolism in ornithine transcarbamylase deficiency.
Yudkoff M; Daikhin Y; Nissim I; Jawad A; Wilson J; Batshaw M
J Clin Invest; 1996 Nov; 98(9):2167-73. PubMed ID: 8903337
[TBL] [Abstract][Full Text] [Related]
23. Hyperammonemic coma due to parenteral nutrition in a woman with heterozygous ornithine transcarbamylase deficiency.
Felig DM; Brusilow SW; Boyer JL
Gastroenterology; 1995 Jul; 109(1):282-4. PubMed ID: 7797025
[TBL] [Abstract][Full Text] [Related]
24. Altered metabolisms of mediators controlling vascular function and enhanced oxidative stress in asymptomatic children with congenital portosystemic venous shunt.
Nagasaka H; Okano Y; Aizawa M; Miida T; Yorifuji T; Tajima G; Sakura N; Takatani T; Sanayama Y; Sugamoto K; Mayumi M; Kobayashi K; Hirano K; Takayanagi M; Tsukahara H
Metabolism; 2010 Jan; 59(1):107-13. PubMed ID: 19766269
[TBL] [Abstract][Full Text] [Related]
25. A new mouse model of mild ornithine transcarbamylase deficiency (spf-j) displays cerebral amino acid perturbations at baseline and upon systemic immune activation.
Tarasenko TN; Rosas OR; Singh LN; Kristaponis K; Vernon H; McGuire PJ
PLoS One; 2015; 10(2):e0116594. PubMed ID: 25647322
[TBL] [Abstract][Full Text] [Related]
26. A pilot study of in vivo liver-directed gene transfer with an adenoviral vector in partial ornithine transcarbamylase deficiency.
Raper SE; Yudkoff M; Chirmule N; Gao GP; Nunes F; Haskal ZJ; Furth EE; Propert KJ; Robinson MB; Magosin S; Simoes H; Speicher L; Hughes J; Tazelaar J; Wivel NA; Wilson JM; Batshaw ML
Hum Gene Ther; 2002 Jan; 13(1):163-75. PubMed ID: 11779420
[TBL] [Abstract][Full Text] [Related]
27. Use of keto acids in inborn errors of urea synthesis.
Brusilow S; Batshaw M; Walser M
Curr Concepts Nutr; 1979; 8():65-75. PubMed ID: 527359
[TBL] [Abstract][Full Text] [Related]
28. Secondary carnitine deficiency in hyperammonemic attacks of ornithine transcarbamylase deficiency.
Ohtani Y; Ohyanagi K; Yamamoto S; Matsuda I
J Pediatr; 1988 Mar; 112(3):409-14. PubMed ID: 3346778
[TBL] [Abstract][Full Text] [Related]
29. Fatal clinical course of ornithine transcarbamylase deficiency in an adult heterozygous female patient.
Heringlake S; Böker K; Manns M
Digestion; 1997; 58(1):83-6. PubMed ID: 9018015
[TBL] [Abstract][Full Text] [Related]
30. [Living related liver transplantation for patients with ornithine transcarbamylase deficiency].
Tazuke M; Murakawa M; Nakao S; Mukaida K; Toda H; Mori K
Masui; 1997 Jun; 46(6):783-7. PubMed ID: 9223881
[TBL] [Abstract][Full Text] [Related]
31. Hyperammonemia in ornithine transcarbamylase-deficient recipients following living donor liver transplantation from heterozygous carrier donors.
Rahayatri TH; Uchida H; Sasaki K; Shigeta T; Hirata Y; Kanazawa H; Mali V; Fukuda A; Sakamoto S; Kasahara M
Pediatr Transplant; 2017 Feb; 21(1):. PubMed ID: 27891735
[TBL] [Abstract][Full Text] [Related]
32. [Ornithine transcarbamylase deficiency. Biochemical studies in the diagnosis of 4 cases and the identification of carriers].
Briones Godino P; Vilaseca Busca MA; Alvarez Dominguez L; Rodes Monegal M; Campistol Plana J
An Esp Pediatr; 1991 May; 34(5):360-4. PubMed ID: 1883110
[TBL] [Abstract][Full Text] [Related]
33. Reduced citrulline availability by OTC deficiency in mice is related to reduced nitric oxide production.
Luiking YC; Hallemeesch MM; van de Poll MC; Dejong CH; de Jonge WJ; Lamers WH; Deutz NE
Am J Physiol Endocrinol Metab; 2008 Dec; 295(6):E1315-22. PubMed ID: 18697914
[TBL] [Abstract][Full Text] [Related]
34. Clinical and biochemical heterogeneity in females of a large pedigree with ornithine transcarbamylase deficiency due to the R141Q mutation.
Ahrens MJ; Berry SA; Whitley CB; Markowitz DJ; Plante RJ; Tuchman M
Am J Med Genet; 1996 Dec; 66(3):311-5. PubMed ID: 8985493
[TBL] [Abstract][Full Text] [Related]
35. Are asymptomatic carriers of OTC deficiency always asymptomatic? A multicentric retrospective study of risk using the UCDC longitudinal study database.
Sen K; Izem R; Long Y; Jiang J; Konczal LL; McCarter RJ; ; Gropman AL; Bedoyan JK
Mol Genet Genomic Med; 2024 Apr; 12(4):e2443. PubMed ID: 38634223
[TBL] [Abstract][Full Text] [Related]
36. Father-to-daughter transmission in late-onset OTC deficiency: an underestimated mechanism of inheritance of an X-linked disease.
Siri B; Olivieri G; Lepri FR; Poms M; Goffredo BM; Commone A; Novelli A; Häberle J; Dionisi-Vici C
Orphanet J Rare Dis; 2024 Jan; 19(1):3. PubMed ID: 38167094
[TBL] [Abstract][Full Text] [Related]
37. Postchemotherapy hyperammonemic encephalopathy emulating ornithine transcarbamoylase (OTC) deficiency.
Chan JS; Harding CO; Blanke CD
South Med J; 2008 May; 101(5):543-5. PubMed ID: 18414167
[TBL] [Abstract][Full Text] [Related]
38. Hyperammonemic coma in an ornithine transcarbamylase mutation carrier following antepartum corticosteroids.
Lipskind S; Loanzon S; Simi E; Ouyang DW
J Perinatol; 2011 Oct; 31(10):682-4. PubMed ID: 21956151
[TBL] [Abstract][Full Text] [Related]
39. Survival after treatment with phenylacetate and benzoate for urea-cycle disorders.
Enns GM; Berry SA; Berry GT; Rhead WJ; Brusilow SW; Hamosh A
N Engl J Med; 2007 May; 356(22):2282-92. PubMed ID: 17538087
[TBL] [Abstract][Full Text] [Related]
40. Long-term treatment of girls with ornithine transcarbamylase deficiency.
Maestri NE; Brusilow SW; Clissold DB; Bassett SS
N Engl J Med; 1996 Sep; 335(12):855-9. PubMed ID: 8778603
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
